Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1934201

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1nc2cc(F)ccc2nc1NC(=O)N1CCN(c2cc(C)cc(C)c2)CC1
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL1934201
Phase Preclinical
Structure Type MOL
InChI Key ZQLBOHHYQIJYTD-UHFFFAOYSA-N
11
Targets
11
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names

Molecular Properties

409.5
MW (Da)
3.75
ALogP
5
HBA
1
HBD
70.6
PSA (Ų)
0.71
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C22H24FN5O2
MW 409.47
Aromatic Rings 3
Heavy Atoms 30
NP-Likeness -1.69

Activity Summary

IC50 11 meas. best 6.6

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
MKN-45
CHEMBL614354
 IC50 6.6 6.6 250.0 1
OVCAR-3
CHEMBL614213
 IC50 6.54 6.54 290.0 1
NON-PROTEIN TARGET
CHEMBL3879801
 IC50 6.5 6.5 320.0 1
HeLa
CHEMBL399
 IC50 6.43 6.43 370.0 1
HCT-116
CHEMBL394
 IC50 6.4 6.4 400.0 1
A549
CHEMBL392
 IC50 6.38 6.38 420.0 1
HepG2
CHEMBL395
 IC50 6.32 6.32 480.0 1
Hs-578T
CHEMBL614645
 IC50 6.3 6.3 500.0 1
SK-MEL-28
CHEMBL614919
 IC50 6.26 6.26 550.0 1
PANC-1
CHEMBL614139
 IC50 6.25 6.25 560.0 1
PC-3
CHEMBL390
 IC50 6.16 6.16 700.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
MKN-45 IC50 = 250.0 nM 6.6 Anticancer activity against human MKN45 cells after 96 hrs by SRB assay 22226981
OVCAR-3 IC50 = 290.0 nM 6.54 Anticancer activity against human OVCAR3 cells after 96 hrs by SRB assay 22226981
NON-PROTEIN TARGET IC50 = 320.0 nM 6.5 Anticancer activity against human UMRC2 cells after 96 hrs by SRB assay 22226981
HeLa IC50 = 370.0 nM 6.43 Anticancer activity against human HeLa cells after 96 hrs by SRB assay 22226981
HCT-116 IC50 = 400.0 nM 6.4 Anticancer activity against human HCT116 cells after 96 hrs by SRB assay 22226981
A549 IC50 = 420.0 nM 6.38 Anticancer activity against human A549 cells after 96 hrs by SRB assay 22226981
HepG2 IC50 = 480.0 nM 6.32 Anticancer activity against human HepG2 cells after 96 hrs by SRB assay 22226981
Hs-578T IC50 = 500.0 nM 6.3 Anticancer activity against human Hs578T cells after 96 hrs by SRB assay 22226981
SK-MEL-28 IC50 = 550.0 nM 6.26 Anticancer activity against human SK-MEL-28 cells after 96 hrs by SRB assay 22226981
PANC-1 IC50 = 560.0 nM 6.25 Anticancer activity against human PANC1 cells after 96 hrs by SRB assay 22226981
PC-3 IC50 = 700.0 nM 6.16 Anticancer activity against human PC3 cells after 96 hrs by SRB assay 22226981

Literature References

PubMed DOI Target Context # Activities
22226981 10.1016/j.bmc.2011.12.026 Hs-578T 1
22226981 10.1016/j.bmc.2011.12.026 NON-PROTEIN TARGET 1
22226981 10.1016/j.bmc.2011.12.026 PANC-1 1
22226981 10.1016/j.bmc.2011.12.026 A549 1
22226981 10.1016/j.bmc.2011.12.026 MKN-45 1
22226981 10.1016/j.bmc.2011.12.026 HepG2 1
22226981 10.1016/j.bmc.2011.12.026 HCT-116 1
22226981 10.1016/j.bmc.2011.12.026 PC-3 1
22226981 10.1016/j.bmc.2011.12.026 HeLa 1
22226981 10.1016/j.bmc.2011.12.026 SK-MEL-28 1
22226981 10.1016/j.bmc.2011.12.026 OVCAR-3 1

Data from ChEMBL 36 via Core Engine